Standardized Botanical Extracts Portfolio
Batch-verified phytopharmaceutical ingredients and clinical-grade extracts manufactured under cGMP, ISO, and HACCP quality standards.
Ginkgo Extract EGb 761: The Golden Standard in Neurovascular Health
EGb 761 represents the internationally validated, clinically referenced extract profile of Ginkgo biloba L. leaves. We dissect the analytical fingerprinting, chemical composition, and mechanism of action required by enterprise buyers.
22.0% – 27.0% Flavonol Glycosides
Standardized quantification of quercetin, kaempferol, and isorhamnetin calculated as flavonol glycosides by HPLC. These bioflavonoids scavenge oxygen-derived free radicals, inhibit lipid peroxidation, and preserve mitochondrial endothelial membrane stability.
5.0% – 7.0% Terpene Lactones
Equally partitioned between Ginkgolides A, B, C (2.8% – 3.4%) and Bilobalide (2.6% – 3.2%). Ginkgolide B provides potent antagonism against Platelet-Activating Factor (PAF), enhancing microvascular capillary perfusion and decreasing blood viscosity.
Controlled Ginkgolic Acids (< 5 ppm)
Ginkgolic acids are alkylphenols exhibiting known cytotoxicity, allergenicity, and genotoxic risks. Our industrial multi-phase continuous countercurrent extraction depletes ginkgolic acids below 5 ppm (EP standard) and ultralow batches < 1 ppm.
| Analytical Parameter | USP Monograph Standard | European Pharmacopoeia (EP 11.0) | UniCare Bio-Tech Certified Release | Methodology |
|---|---|---|---|---|
| Flavonol Glycosides Assay | 22.0% – 27.0% | 22.0% – 27.0% | 24.2% – 25.8% Guaranteed | HPLC (Hydrolysis Method) |
| Total Terpene Lactones | 5.4% – 12.0% | 6.0% – 8.0% | 6.0% – 6.8% | HPLC-ELSD / UHPLC |
| Bilobalide Content | 2.6% – 5.8% | 2.6% – 3.2% | 2.8% – 3.1% | HPLC-ELSD |
| Ginkgolides A+B+C | 2.8% – 6.2% | 2.8% – 3.4% | 3.0% – 3.3% | HPLC-ELSD |
| Ginkgolic Acids Residue | ≤ 5.0 ppm | ≤ 5.0 ppm | < 1.0 ppm (Ultra-Pure Grade) | LC-MS/MS |
| Heavy Metals (Pb, Cd, As, Hg) | Meets USP <232> | Meets EP 2.4.27 | Pb<0.5, Cd<0.1, As<0.5, Hg<0.05 ppm | ICP-MS |
China Factory Sourcing & Manufacturing Supremacy
China accounts for more than 70% of the world's raw Ginkgo biloba leaf production. UniCare leverages upstream geographic integration and proprietary manufacturing engineering to offer consistent scale and security.
Origin Cultivation Bases
Contracted, traceable plantations across Jiangsu, Shandong, and Sichuan provinces ensure GAP-compliant harvest intervals, optimum secondary metabolite concentrations, and strict control over agricultural runoffs.
Continuous Countercurrent Extraction
Industrial continuous countercurrent production systems maximize botanical active yields while preserving thermolabile lactones, drastically lowering carbon footprint and minimizing batch-to-batch variability.
Integrated QC Laboratories
Equipped with Agilent 1290 UHPLC, Shimadzu ELSD detectors, GC-MS/MS, and ICP-MS systems. Every lot undergoes rigorous testing for assay compounds, organic solvents, pesticides, and microbial counts.
Scalable Export Logistics
Streamlined customs clearance documentation, bonded warehousing capabilities, ocean consolidated cargo, and air priority fulfillment to North America, Europe, Southeast Asia, and Latin America.
Localized Support & Regulatory Compliance
Phytopharmaceutical ingredients require comprehensive dossier submissions. UniCare guarantees complete compliance documents for seamless regional qualification.
European Union & EMA Requirements
Fully compliant with the European Medicines Agency (EMA) Community herbal monograph on Ginkgo biloba L., folium. We supply complete CEP qualification portfolios, residual solvent validation per EP 5.4, and PAH (polycyclic aromatic hydrocarbons) screening per EU 2023/915.
US FDA & Dietary Supplement cGMP
Adherence to 21 CFR Part 111 and Part 117. Batches are screened to preclude adulteration by exogenous rutin, quercetin, or sophora extract using USP-verified HPLC ratio methods. FSMA Foreign Supplier Verification Program (FSVP) dossiers ready.
Full Technical Dossier (CTD Support)
Each shipment is coupled with a Batch-Specific Certificate of Analysis (COA), Technical Data Sheet (TDS), Safety Data Sheet (SDS), GMO-Free Declaration, Allergen Statements, BSE/TSE statements, and Method of Analysis (MOA) validation protocols.
Procurement Demands & Targeted Application Profiles
From pharmaceutical-grade anti-vertigo therapeutics to clean-label nootropics and cellular skincare formulations, Ginkgo Extract EGb 761 serves distinct regulatory and commercial needs.
Nootropic & Cognitive Formulations
Synergistic integration into memory enhancement capsules, energy stacks, and neuroprotective dietary supplements targeting executive focus, neuroplasticity, and age-related cognitive decline.
Pharma Otology & Peripheral Flow
Prescribed actively for symptomatic relief of tinnitus, inner ear microvascular ischemia, vestibular vertigo, and intermittent claudication associated with peripheral arterial occlusive conditions.
Cardiovascular & Anti-Aging Blends
Formulated into healthy aging products alongside CoQ10, Resveratrol, and Quercetin to reduce systemic arterial stiffening, combat oxidative stress, and optimize capillary elasticity.
Cosmeceuticals & Topical Serums
Water-dispersible, low-color grades utilized in advanced dermocosmetics to improve cutaneous capillary microcirculation, reduce erythema, and neutralize UV-induced oxidative cell damage.
Ginkgo Extract EGb 761 Market Trends & Sourcing Outlook
Key developments driving global botanical procurement strategies and analytical scrutiny through 2030.
Combatting Economically Motivated Adulteration (EMA)
Global regulatory authorities have increased surveillance against artificial spiking with cheap rutin, kaempferol, or sophora japonica derivatives. Leading brands require botanical DNA tracing, stable carbon isotope testing (13C/12C IRMS), and HPLC peak-ratio verification.
The Ultra-Low Ginkgolic Acid Transition
While standard pharmacopoeias stipulate <5 ppm ginkgolic acids, top-tier international nutraceutical formulations now specify <1 ppm. Advanced liquid-liquid partitioning and selective resin chromatography enable us to achieve undetectable levels without degrading terpene lactones.
Bioavailability Enhancement Technologies
Novel delivery systems such as Phytosome phospholipid complexes, nano-encapsulations, and water-soluble microemulsions are surging. These specialized delivery vectors multiply oral bioavailability by up to 300% across the blood-brain barrier.
Frequently Asked Technical & Sourcing Questions
Clear answers to questions posed by QA directors, procurement officers, and regulatory specialists qualifying EGb 761 suppliers.
What precisely defines an extract as true EGb 761 standard?
How does UniCare detect and prevent Ginkgo adulteration?
Which certifications do UniCare partner extraction plants hold?
Can you supply Ginkgo extract with ginkgolic acids < 1 ppm?
What analytical testing is performed on each release batch?
What are the standard packaging, shelf life, and MOQs?
Related Active Phytochemical Ingredients
Procure Certified Plant Extracts Directly
Connect with our engineering and sourcing departments for technical specifications, batch documentation, and lab-scale evaluation quantities.